4//SEC Filing
JORDAN ANDREW R 4
Accession 0001104659-23-005137
CIK 0000861838other
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 9:47 PM ET
Size
7.7 KB
Accession
0001104659-23-005137
Insider Transaction Report
Form 4
Aceragen, Inc.ACGN
JORDAN ANDREW R
Chief Strategy Officer
Transactions
- Exercise/Conversion
Series Z Convertible Preferred Stock
2023-01-17−6,843→ 0 total→ Common Stock (402,529 underlying) - Exercise/Conversion
Common Stock
2023-01-17+402,529→ 451,890 total
Footnotes (2)
- [F1]On January 17, 2023, the Issuer's Series Z Non-Voting Convertible Preferred Stock, par value $0.01 per share ("Series Z Preferred Stock") converted into shares of common stock of the Issuer, par value $0.001 per share ("Common Stock"). By operation of the certificate of designation for the Series Z Preferred Stock, each share of Series Z Preferred Stock was converted into 1,000 shares of Common Stock for no consideration.
- [F2]Reflects a 1-for-17 reverse stock split, which became effective on January 17, 2023 at 4:59 pm Eastern Time.
Documents
Issuer
Aceragen, Inc.
CIK 0000861838
Entity typeother
Related Parties
1- filerCIK 0001206350
Filing Metadata
- Form type
- 4
- Filed
- Jan 18, 7:00 PM ET
- Accepted
- Jan 19, 9:47 PM ET
- Size
- 7.7 KB